In this paper, the evolution of postmenopausal hormone replacement is reviewed, with an evidence-based approach and particular emphasis on the Heart and Estrogen/Progestin Replacement Study and Women's Health Initiative reports. This therapy will continue to evolve and have pertinence for women with menopausal symptoms and for osteoporosis prevention in selected patients.